SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-014949
Filing Date
2023-08-15
Accepted
2023-08-15 07:00:14
Documents
12
Period of Report
2023-08-14
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K mrns-20230814x8k.htm   iXBRL 8-K 39959
  Complete submission text file 0001558370-23-014949.txt   163099

Data Files

Seq Description Document Type Size
2 EX-101.SCH mrns-20230814.xsd EX-101.SCH 3117
3 EX-101.LAB mrns-20230814_lab.xml EX-101.LAB 16590
4 EX-101.PRE mrns-20230814_pre.xml EX-101.PRE 10712
6 EXTRACTED XBRL INSTANCE DOCUMENT mrns-20230814x8k_htm.xml XML 5063
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 231173184
SIC: 2834 Pharmaceutical Preparations